Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
This medication is approved for adults with obesity or those who are overweight and have at least one weight-related condition, such as type 2 diabetes, heart disease, stroke, or obstructive sleep apnea
Results inform whether to continue escalation or optimize the current dose
For example, in Canada, attention is already shifting towards newer entrants like tirzepatide (Mounjaro/Zepbound), which has demonstrated superior efficacy in weight loss in the head-to-head SURMOUNT-5 trial iii and is gaining momentum
The pharmacy has conducted temperature stability studies showing the medication remains effective for up to 7 days at temperatures as high as 104F (40C) and can stay stable at room temperature for up to 30 days
US$ 25.59
US$ 29.71
US$ 26.87
US$ 21.04
)
US$ 24.80
